Status:
UNKNOWN
Feasibility of Adjunctive BLT for Amelioration of Fatigue in Chinese Cancer Patients Admitted to a Palliative Care Unit
Lead Sponsor:
Hospital Authority, Hong Kong
Conditions:
Fatigue
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Fatigue is the most common symptom in palliative care patients who have advanced cancer. Fatigue is also one of the most underreported hence under-treated symptoms. Patients may perceive it as a condi...
Detailed Description
Fatigue is the most common symptom in palliative care patients who have advanced cancer, ranging from 59% to 77% depends on the assessment method (1). There is limited local data on the prevalence of ...
Eligibility Criteria
Inclusion
- Adult patient aged 18 years old or above
- Chinese ethnic group
- Diagnosis of incurable cancer
- A score of \>=3 in Brief Fatigue Inventory after a period of standard care
Exclusion
- Patients who are imminently dying
- Patients who are undergoing chemotherapy or radiotherapy
- Patients who have history of epilepsy, brain tumour, brain metastasis
- Patients who are blind or have retinal disease
- Patents who have photosensitive skin condition
- Patients who have history of bipolar disorder as BLT has been suggested to increase the risk of manic swing in patients with bipolar disorder
- Patients who have their dosage of antidepressants adjusted within 6 weeks
- Patients who have difficulties to communicate effectively
- Patients with impaired mental status precluding the completion of the questionnaire (AMT \<5)
- Patients who are unable to give valid consent
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2020
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT04525924
Start Date
August 1 2020
End Date
November 1 2020
Last Update
September 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shatin Hospital
Hong Kong, Hong Kong